401 related articles for article (PubMed ID: 28743428)
1. A therapeutic benefit of daptomycin against glycopeptide-resistant gram-positive cocci bloodstream infections under neutropenia.
Matsuda K; Koya J; Toyama K; Ikeda M; Arai S; Nakamura F; Okugawa S; Moriya K; Kurokawa M
J Infect Chemother; 2017 Nov; 23(11):788-790. PubMed ID: 28743428
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant Enterococcus bacteremia in a child with acute myeloid leukemia: successful treatment with daptomycin.
Büyükcam A; Karadağ Öncel E; Özsürekçi Y; Cengiz AB; Kuşkonmaz B; Sancak B
Arch Argent Pediatr; 2016 Dec; 114(6):e432-e435. PubMed ID: 27869427
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
4. [Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Garnacho-Montero J; Amaya-Villar R; Gómez-Grande ML; Jerez V; Lorente-Ramos L; Loza A; Martínez A; Pozo JC; Sierra R; Pomares J; de la Torre MV; Ortiz C
Rev Esp Quimioter; 2011 Mar; 24(1):13-24. PubMed ID: 21412665
[TBL] [Abstract][Full Text] [Related]
5. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].
Yang QW; Wang H; Sun HL; Xu YC; Xie XL; Chen MJ
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):220-4. PubMed ID: 19576091
[TBL] [Abstract][Full Text] [Related]
6. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
[No Abstract] [Full Text] [Related]
7. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of treatments used in infections caused by gram-positive multiresistant cocci in critically ill patients admitted to the ICU].
Álvarez-Lerma F; Palomar Martínez M; Olaechea Astigarraga P; Insausti Ordeñana J; López Pueyo MJ; Gracia Arnillas MP; Gimeno Costa R; Seijas Betolaza I
Rev Esp Quimioter; 2012 Mar; 25(1):65-73. PubMed ID: 22488544
[TBL] [Abstract][Full Text] [Related]
9. [Case report: two Leuconostoc bacteremia cases].
Aygün H; Bozkurt GY; Memikoğlu O; Cokça F
Mikrobiyol Bul; 2005 Apr; 39(2):225-8. PubMed ID: 16128035
[TBL] [Abstract][Full Text] [Related]
10. A febrile neutropenic patient with Enterococcus gallinarum sepsis treated with daptomycin and gentamicin.
Barber GR; Lauretta J; Saez R
Pharmacotherapy; 2007 Jun; 27(6):927-32. PubMed ID: 17542774
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
King EA; McCoy D; Desai S; Nyirenda T; Bicking K
J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
[TBL] [Abstract][Full Text] [Related]
12. Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.
Crank CW; Scheetz MH; Brielmaier B; Rose WE; Patel GP; Ritchie DJ; Segreti J
Clin Ther; 2010 Sep; 32(10):1713-9. PubMed ID: 21194593
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Gram-positive cocci infection and the therapeutic effect after liver transplantation.
Wu X; Wu L; Shu L; Xie C; Wan Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):707-715. PubMed ID: 37539573
[TBL] [Abstract][Full Text] [Related]
14. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.
Munita JM; Mishra NN; Alvarez D; Tran TT; Diaz L; Panesso D; Reyes J; Murray BE; Adachi JA; Bayer AS; Arias CA
Clin Infect Dis; 2014 Nov; 59(9):1277-80. PubMed ID: 25107294
[TBL] [Abstract][Full Text] [Related]
15. Management of gram-positive coccal bacteremia and hemodialysis.
Fitzgibbons LN; Puls DL; Mackay K; Forrest GN
Am J Kidney Dis; 2011 Apr; 57(4):624-40. PubMed ID: 21333430
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin for line-related Leuconostoc bacteraemia.
Golan Y; Poutsiaka DD; Tozzi S; Hadley S; Snydman DR
J Antimicrob Chemother; 2001 Mar; 47(3):364-5. PubMed ID: 11222577
[No Abstract] [Full Text] [Related]
17. [Daptomycin in the context of antimicrobial resistance in Gram-positive bacteria].
Candel González FJ
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():10-6. PubMed ID: 22541970
[TBL] [Abstract][Full Text] [Related]
18. [Daptomycin: pharmacological characteristics and its role in the treatment of gram positive infections].
Araos R; García P; Chanqueo L; Labarca J
Rev Chilena Infectol; 2012 Apr; 29(2):127-31. PubMed ID: 22689024
[TBL] [Abstract][Full Text] [Related]
19. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
Togneri A; Lopardo H; Corso A
Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
DiPippo AJ; Tverdek FP; Tarrand JJ; Munita JM; Tran TT; Arias CA; Shelburne SA; Aitken SL
J Infect; 2017 Mar; 74(3):243-247. PubMed ID: 27845153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]